European Diabetes Market

SUMMARY

Research Overview

This research service is available through our Pharmaceutical and Clinical Diagnostics Growth Partnership Services program. With this program you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.

TABLE OF CONTENTS

• 1. Executive Summary
  • 1. Overview
    • 1. Executive Summary of the European Diabetes Market
• 2. Introduction
  • 1. Disease State Overview
    • 1. Epidemiology
  • 2. Research Methodology
    • 1. Research Methodology for the European Diabetes Market
    • 2. Assumptions and Limitations
• 3. Industry Challenges
  • 1. Challenges and Issues
    • 1. Challenges Facing the European Diabetes Market
• 4. European Diabetes Market Analysis
  • 1. Total European Diabetes Market
    • 1. Market Overview and Segmentation
    • 2. Revenue Forecasts
  • 2. Insulin Market
    • 1. Market Overview
    • 2. Trends by Segment
    • 3. Market Engineering Measurements
    • 4. Market Drivers
    • a. Increasing Diabetic Population Puts More Pressure on Governments to Reduce Costs Incurred Because of Complications
    • b. Awareness of the Importance of Tight Glycaemic Control
    • c. Acceptance of Insulin Therapy among the Type 2 Diabetic Population
    • d. Introduction of More Convenient Forms of Insulin Delivery
    • 5. Market Restraints
    • a. Cost of Insulin Therapy
    • b. Resistance to Insulin Therapy
    • 6. Impact Probability Analysis
    • 7. Competitive Structure
    • 8. Market Share Analysis
    • 9. Revenue Forecasts
  • 3. Oral Anti-Diabetic (OAD) Drugs Market
    • 1. Market Overview
    • 2. Trends by Segment
    • 3. Market Engineering Measurements
    • 4. Market Drivers
    • 5. Market Restraints
    • 6. Impact Probability Analysis
    • 7. Competitive Structure
    • 8. Revenue Forecasts
  • 4. Diabetes Drugs in Pipeline
    • 1. Pipeline Analysis
• 5. German Diabetes Market
  • 1. Market Engineering Research
    • 1. Market Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
• 6. The United Kingdom Diabetes Market
  • 1. Market Engineering Research
    • 1. Market Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
• 7. French Diabetes Market
  • 1. Market Engineering Research
    • 1. Market Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
• 8. Italian Diabetes Market
  • 1. Market Engineering Research
    • 1. Market Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
• 9. Spanish Diabetes Market
  • 1. Market Engineering Research
    • 1. Market Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
• 10. Scandinavian Diabetes Market
  • 1. Market Engineering Research
    • 1. Market Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
• 11. Benelux Diabetes Market
  • 1. Market Engineering Research
    • 1. Market Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
• 12. Strategic Recommendations
  • 1. Market Engineering Recommendations
    • 1. Strategic Recommendations for the European Diabetes Market
• 13. Database of Key Industry Participants
  • 1. Key Industry Participants
    • 1. Major Participants
• 15. Appendix
  • 1. Decision Support Database
    • 1. Diabetes Incidence
    • 2. Diabetes Prevalence
    • 3. Diabetes Prevalence Percent
    • 4. Obesity Prevalence
    • 5. Total Healthcare Expenditure